This episode of Boston Scientific Talks features Boston Scientific's entrance into advanced endoluminal surgery and obesity management, spearheaded by its acquisition of Apollo Endosurgery in November 2022. 

Chief Medical Officer, Endoscopy Brian Dunkin, MD and SVP and President, Endoscopy Mike Jones explore the strategic value of this acquisition and the integration of Apollo's technology, which is poised to potentially revolutionize endoscopic procedures.

The discussion centers on the potential of Apollo's technology in broadening Boston Scientific's endoluminal surgery capabilities. Jones highlights the addition of the Overstitch device, which enhances the company's ability to perform endoscopic suturing and endoluminal sleeve gastroplasty, addressing obesity through minimally invasive means. Additionally, Dr. Dunkin provides a clinical perspective on how these technologies represent a paradigm shift in surgery, moving towards scarless operations.

They also explore the role of GLP-1 medications in the medical device market, underlining how pharmaceuticals complement devices in obesity treatment. The episode gives a comprehensive view of Boston Scientific's strategy in integrating Apollo's technology into its portfolio, the challenges of training and adoption, and the optimism for future innovations in minimally invasive procedures.

Thank you to Freudenberg Medical for sponsoring this episode. Please visit Freudenberg Medical’s dedicated webpage at https://www.freudenbergmedical.com/en/single-use-scopes/ to learn more about their specific expertise in this area and to access Freudenberg Medical’s trend paper on the topic.

Thank you for listening to the Boston Scientific Podcast.

Subscribe to this podcast on every major podcast platform, https://linktr.ee/DeviceTalks

Boston Scientific Jones and Dunkin detail why Apollo tech could launch endosurgery revolution

In this episode of AbbottTalks, Sandra Lesenfants, SVP of Abbott’s structural heart business, discusses the latest advancements in structural heart care, focusing on Abbott's transformative TriClip device for tricuspid regurgitation.

Lesenfants highlights Abbott’s commitment to patient-centered innovation, emphasizing the importance of creating solutions that meet patients’ needs through safe and effective technologies. She also shares Abbott’s approach to expanding access to minimally invasive therapies, particularly in underserved populations worldwide, and the role of physician partnerships in advancing structural heart interventions.

Lastly, Lesenfants underscores the company’s efforts to increase diversity in clinical trials, noting the importance of intentional inclusivity across gender and ethnicity to better serve diverse patient populations.

Thank you to Confluent Medical Technologies for sponsoring this episode of AbbottTalks. For more information on how Confluent Medical works with medical device companies, visit https://confluentmedical.com/.

Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.

Abbott’s Lesenfants shares TriClip progress, patient-centered innovation & clinical trial diversity

The DeviceTalks Podcast Network delivers news, insights and commentary from MedTech industry leaders, primarily from the largest OEMs in healthcare. Our podcasts will inspire MedTech professionals to create better MedTech devices and companies.

Explore the DeviceTalks Podcast Network, home to more than 11 podcasts:

• DeviceTalks Weekly
• AbbottTalks
• Boston Scientific Talks
• DeviceTalks AI
• IntuitiveTalks
• MedtechWOMEN Talks
• MedtronicTalks
• Neuro Innovation Talks: J&J MedTech Neuro
• Structural Heart Talks: Edwards Lifesciences
• Ortho Innovation Talks: Zimmer Biomet
• StrykerTalks

WATCH our video podcasts on www.youtube.com/@DeviceTalks

Connect with the hosts:
Tom Salemi, Editorial Director, DeviceTalks https://www.linkedin.com/in/tom-salemi-7118948/
Kayleen Brown, Managing Editor, DeviceTalks https://www.linkedin.com/in/kayleenbrown/

Learn more about DeviceTalks - Podcasts • Conferences • Webinars - www.devicetalks.com

Boston Scientific Jones and Dunkin detail why Apollo tech could launch endosurgery revolution

DeviceTalks

Related tracks